Avantor (AVTR) Stock Forecast & Price Target

$27.20

+0.32 (+1.19%)

(As of 09/16/2024 ET)

Avantor - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 16 Analyst Ratings

Based on 16 Wall Street analysts who have issued ratings for Avantor in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 4 have given a hold rating, and 12 have given a buy rating for AVTR.

Consensus Price Target

$27.40
0.72% Upside

High Forecast	$31.00
Average Forecast	$27.40
Low Forecast	$22.00

According to the 16 analysts' twelve-month price targets for Avantor, the average price target is $27.40. The highest price target for AVTR is $31.00, while the lowest price target for AVTR is $22.00. The average price target represents a forecasted upside of 0.72% from the current price of $27.21.

Type	Current Forecast 9/17/23 to 9/16/24	1 Month Ago 8/18/23 to 8/17/24	3 Months Ago 6/19/23 to 6/18/24	1 Year Ago 9/17/22 to 9/17/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	12 Buy rating(s)	11 Buy rating(s)	12 Buy rating(s)	9 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$27.40	$27.21	$26.71	$26.20
Forecasted Upside	0.72% Upside	14.02% Upside	16.60% Upside	22.89% Upside

China Stockpiling Gold “Like No Tomorrow” (Ad)

For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… .

Click here now to get your free 'De-Dollarization' Guide.

AVTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

AVTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Avantor Stock vs. The Competition

Type	Avantor	Medical Companies	S&P 500
Consensus Rating Score	2.75	2.77	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	0.72% Upside	1,120.86% Upside	7.93% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/27/2024	Wells Fargo & Company 3 of 5 stars	B. Couillard Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$30.00	+17.14%
7/29/2024	Morgan Stanley 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$28.00 ➝ $29.00	+10.81%
7/29/2024	TD Cowen 4 of 5 stars		Boost Target	Buy ➝ Buy	$28.00 ➝ $31.00	+18.32%
7/29/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$25.00 ➝ $28.00	+7.36%
7/29/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$31.00 ➝ $31.00	+20.06%
7/29/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$27.00 ➝ $28.00	+9.37%
This Crypto Coin Could 10x FASTER Than Bitcoin (Ad) The Bitcoin Halving ignited the 2024 boom, and altcoins are primed to SKYROCKET. Last year we tipped off our community with altcoins that delivered EXPLOSIVE gains. Now, we've uncovered an even bigger potential winner for the 2024 Bitcoin Halving bull run. Click here to take advantage of this time-sensitive offer.
7/29/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$26.00 ➝ $27.00	+5.47%
7/10/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Donnelly Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$30.00 ➝ $23.00	+10.13%
7/2/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$28.00 ➝ $27.00	+30.88%
4/18/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$23.00 ➝ $25.00	+2.54%
2/15/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$25.00 ➝ $29.00	+18.13%
2/15/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$26.00 ➝ $29.00	+18.08%
1/26/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$22.50 ➝ $26.00	+18.51%
12/13/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Peer Perform
12/7/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$23.00 ➝ $26.00	+23.99%
9/28/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform	$22.00	+5.90%
7/31/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Larew Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
7/30/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$27.00 ➝ $24.00	+12.78%
5/1/2023	888 Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Maintains
11/1/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$26.00	+30.13%
10/31/2022	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral	$32.00 ➝ $25.00	+30.07%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 08:25 PM ET.

AVTR Forecast - Frequently Asked Questions

What is Avantor's forecast for 2024?: According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Avantor is $27.40, with a high forecast of $31.00 and a low forecast of $22.00.
Should I buy or sell Avantor stock right now?: 16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last twelve months. There are currently 4 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AVTR shares.
Does Avantor's stock price have much upside?: According to analysts, Avantor's stock has a predicted upside of 14.24% based on their 12-month stock forecasts.
Has Avantor been downgraded by Wall Street analysts recently?: Over the previous 90 days, Avantor's stock had 1 downgrade by analysts.
What analysts cover Avantor?: Avantor has been rated by research analysts at Barclays, Citigroup, Evercore ISI, Morgan Stanley, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, TD Cowen, and Wells Fargo & Company in the past 90 days.
Do Wall Street analysts like Avantor more than its competitors?: Analysts like Avantor less than other "medical" companies. The consensus rating score for Avantor is 2.75 while the average consensus rating score for "medical" companies is 2.77. Learn more on how AVTR compares to other companies.